Puma Biotechnology Inc Working Capital to Net Assets Ratio
Puma Biotechnology Inc working capital to net assets ratio. Puma Biotechnology Inc (PBYI) has a Working Capital to Net Assets ratio of 62.5% as of December 2025. Working capital of $81.43 Million (current assets of $162.69 Million minus current liabilities of $81.25 Million) is measured against net assets of $130.34 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Puma Biotechnology Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Puma Biotechnology Inc (2008–2025)
Working capital to net assets ratio of Puma Biotechnology Inc from 2008 to 2025. This chart shows how Puma Biotechnology Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 62.5%, reflecting working capital of $81.43 Million against net assets of $130.34 Million USD. See PBYI days of operational coverage to measure how many days the company can operate on defensive assets alone.
Puma Biotechnology Inc Working Capital to Net Assets Ratio by Year (2008–2025)
Puma Biotechnology Inc working capital to net assets ratio by year from 2008 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Puma Biotechnology Inc from 2008 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Puma Biotechnology Inc assets under control.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 62.5% | $81.43 Million | $130.34 Million | $162.69 Million | $81.25 Million | ▲ +6.5 pp |
| 2024 | 56.0% | $51.55 Million | $92.12 Million | $147.66 Million | $96.11 Million | ▼ -50.3 pp |
| 2023 | 106.3% | $56.80 Million | $53.44 Million | $156.19 Million | $99.38 Million | ▼ -156.6 pp |
| 2022 | 262.9% | $56.80 Million | $21.61 Million | $134.28 Million | $77.48 Million | ▲ +1507.2 pp |
| 2021 | -1244.3% | $30.44 Million | $-2.45 Million | $140.02 Million | $109.59 Million | ▼ -708.5 pp |
| 2020 | -535.8% | $31.88 Million | $-5.95 Million | $146.14 Million | $114.25 Million | ▼ -967.9 pp |
| 2019 | 432.1% | $75.46 Million | $17.46 Million | $166.30 Million | $90.84 Million | ▲ +36.0 pp |
| 2018 | 396.1% | $135.89 Million | $34.31 Million | $203.00 Million | $67.11 Million | ▲ +306.0 pp |
| 2017 | 90.2% | $48.05 Million | $53.30 Million | $106.39 Million | $58.34 Million | ▼ -4.7 pp |
| 2016 | 94.8% | $199.01 Million | $209.82 Million | $236.47 Million | $37.46 Million | ▲ +2.1 pp |
| 2015 | 92.8% | $191.11 Million | $206.01 Million | $223.55 Million | $32.44 Million | ▲ +3.1 pp |
| 2014 | 89.7% | $104.94 Million | $117.05 Million | $149.38 Million | $44.44 Million | ▼ -2.2 pp |
| 2013 | 91.8% | $77.12 Million | $83.99 Million | $96.40 Million | $19.27 Million | ▼ -6.9 pp |
| 2012 | 98.7% | $127.27 Million | $128.91 Million | $148.97 Million | $21.70 Million | ▲ +1.1 pp |
| 2011 | 97.6% | $53.08 Million | $54.37 Million | $53.66 Million | $586.21K | ▼ -2.4 pp |
| 2009 | 100.0% | $138.00 | $138.00 | $2.41K | $2.27K | ▲ +0.0 pp |
| 2008 | 100.0% | $-2.18K | $-2.18K | $73.00 | $2.25K | — |